<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ischemic cerebrovascular disease (<z:hpo ids='HP_0001297'>stroke</z:hpo>) is one of the leading causes of <z:hpo ids='HP_0011420'>death</z:hpo> and long-time disability </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>/reperfusion to any organ triggers a complex series of biochemical events, which affect the structure and function of every organelle and subcellular system of the affected cells </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to investigate the therapeutic efficacy of N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> cysteine (NAC), a precursor of <z:chebi fb="0" ids="16856">glutathione</z:chebi> and a potent <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, to attenuate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury to brain tissue caused by a focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model in rats </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 27 male Sprague-Dawley rats weighing 250-300 g were used in this study </plain></SENT>
<SENT sid="4" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (45 min) was induced in anesthetized rats by occluding the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) with an intra-<z:chebi fb="2" ids="8069">luminal</z:chebi> suture through the internal carotid artery </plain></SENT>
<SENT sid="5" pm="."><plain>The rats were scored post-reperfusion for neurological deficits </plain></SENT>
<SENT sid="6" pm="."><plain>They were then sacrificed after 24 h of reperfusion and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in the brain was assessed by 2,3,5-triphenyl tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC) </plain></SENT>
<SENT sid="7" pm="."><plain>Brain sections were immunostained for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF-alpha) and inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) </plain></SENT>
<SENT sid="8" pm="."><plain>Animals treated with NAC showed a 49.7% (S.E.M.=1.25) reduction in brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and 50% (S.E.M.=0.48) reduction in the neurological evaluation score as compared to the untreated animals </plain></SENT>
<SENT sid="9" pm="."><plain>NAC treatment also blocked the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced expression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor and inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase </plain></SENT>
<SENT sid="10" pm="."><plain>The data suggest that pre-administration of NAC attenuates <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion injury in this <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> model </plain></SENT>
<SENT sid="11" pm="."><plain>This protective effect may be as a result of suppression of TNF-alpha and iNOS </plain></SENT>
</text></document>